MESO
Income statement / Annual
Last year (2024), Mesoblast Limited's total revenue was $5.90 M,
a decrease of 21.32% from the previous year.
In 2024, Mesoblast Limited's net income was -$87.96 M.
See Mesoblast Limited,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
Period Ended |
06/30/2024 |
06/30/2023 |
06/30/2022 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
Operating Revenue |
$5.90 M |
$7.50 M |
$10.21 M |
$7.46 M |
$32.16 M |
$16.72 M |
$17.34 M |
$2.41 M |
$42.55 M |
$23.75 M |
Cost of Revenue |
$41.07 M
|
$54.92 M
|
$63.57 M
|
$85.73 M
|
$81.50 M
|
$75.17 M
|
$5.51 M
|
$12.07 M
|
$29.76 M
|
$23.78 M
|
Gross Profit |
-$35.17 M
|
-$47.42 M
|
-$53.36 M
|
-$78.28 M
|
-$49.34 M
|
-$58.45 M
|
$11.83 M
|
-$9.65 M
|
$12.79 M
|
-$35,000.00
|
Gross Profit Ratio |
1
|
-6.32
|
-5.23
|
-10.5
|
-1.53
|
-3.5
|
0.68
|
-4
|
0.3
|
-0
|
Research and Development Expenses |
$25.35 M
|
$27.19 M
|
$32.82 M
|
$53.01 M
|
$56.19 M
|
$59.82 M
|
$65.93 M
|
$58.91 M
|
$50.01 M
|
$77.59 M
|
General & Administrative Expenses |
$23.63 M
|
$25.37 M
|
$27.21 M
|
$30.87 M
|
$25.61 M
|
$21.63 M
|
$21.91 M
|
$23.01 M
|
$22.50 M
|
$36.17 M
|
Selling & Marketing Expenses |
$0.00
|
$27.73 M
|
$30.76 M
|
$32.72 M
|
$25.31 M
|
$15.36 M
|
$5.51 M
|
$12.07 M
|
$29.76 M
|
$29.21 M
|
Selling, General & Administrative Expenses |
$23.63 M
|
$53.11 M
|
$57.97 M
|
$63.59 M
|
$50.92 M
|
$36.98 M
|
$27.42 M
|
$35.07 M
|
$52.26 M
|
$65.38 M
|
Other Expenses |
$0.00
|
$0.00
|
$30.76 M
|
$32.65 M
|
$25.23 M
|
$15.48 M
|
-$1.31 M
|
$10.53 M
|
$25.92 M
|
$122,000.00
|
Operating Expenses |
$48.98 M
|
$76.79 M
|
$90.79 M
|
$115.06 M
|
$107.56 M
|
$97.88 M
|
$92.03 M
|
$92.50 M
|
$98.44 M
|
$137.14 M
|
Cost And Expenses |
$90.05 M
|
$76.79 M
|
$90.79 M
|
$115.06 M
|
$107.56 M
|
$97.88 M
|
$92.03 M
|
$92.50 M
|
$98.44 M
|
$137.14 M
|
Interest Income |
$0.00
|
$831,000.00
|
$3,000.00
|
$22,000.00
|
$542,000.00
|
$719,000.00
|
$366,000.00
|
$468,000.00
|
$1.08 M
|
$0.00
|
Interest Expense |
$0.00
|
$19.44 M
|
$16.91 M
|
$10.71 M
|
$13.33 M
|
$11.33 M
|
$1.83 M
|
$0.00
|
$9.31 M
|
$10.53 M
|
Depreciation & Amortization |
$1.90 M
|
$4.11 M
|
$4.38 M
|
$4.26 M
|
$3.67 M
|
$2.14 M
|
$2.65 M
|
$3.06 M
|
$2.19 M
|
$1.96 M
|
EBITDA |
-$56.08 M |
-$58.55 M |
-$76.57 M |
-$107.60 M |
-$75.41 M |
-$78.06 M |
-$74.69 M |
-$87.16 M |
-$28.07 M |
-$90.19 M |
EBITDA Ratio |
-10.64
|
-8.67
|
-7.5
|
-14.43
|
-2.34
|
-4.85
|
-4.31
|
-37.29
|
-0.66
|
-4.88
|
Operating Income Ratio |
-9.82
|
-9.24
|
-7.89
|
-14.63
|
-2.33
|
-4.8
|
-4.46
|
-37.33
|
-1.31
|
-4.77
|
Total Other Income/Expenses Net |
-$4.00 M
|
-$12.81 M
|
-$10.48 M
|
$9.47 M
|
-$12.48 M
|
-$18.34 M
|
$9.24 M
|
-$173,000.00
|
-$34.93 M
|
-$4.45 M
|
Income Before Tax |
-$88.15 M
|
-$82.10 M
|
-$91.59 M
|
-$99.63 M
|
-$87.36 M
|
-$98.75 M
|
-$65.98 M
|
-$90.22 M
|
-$90.82 M
|
-$119.37 M
|
Income Before Tax Ratio |
-14.94
|
-10.95
|
-8.97
|
-13.36
|
-2.72
|
-5.91
|
-3.8
|
-37.4
|
-2.13
|
-5.03
|
Income Tax Expense |
$191,000.00
|
-$212,000.00
|
-$239,000.00
|
-$819,000.00
|
-$9.42 M
|
-$8.96 M
|
-$30.69 M
|
-$13.40 M
|
-$86.69 M
|
$6.10 M
|
Net Income |
-$87.96 M
|
-$81.89 M
|
-$91.35 M
|
-$98.81 M
|
-$77.94 M
|
-$89.80 M
|
-$35.29 M
|
-$76.82 M
|
-$4.13 M
|
-$119.37 M
|
Net Income Ratio |
-14.9
|
-10.92
|
-8.95
|
-13.25
|
-2.42
|
-5.37
|
-2.04
|
-31.85
|
-0.1
|
-5.03
|
EPS |
-0.0891 |
-0.0978 |
-0.13 |
-0.16 |
-0.15 |
-0.18 |
-0.0758 |
-0.19 |
-0.0114 |
-0.3 |
EPS Diluted |
-0.0891 |
-0.0976 |
-0.13 |
-0.16 |
-0.15 |
-0.18 |
-0.0758 |
-0.19 |
-0.0114 |
-0.3 |
Weighted Average Shares Out |
$986.71 M
|
$837.73 M
|
$682.71 M
|
$605.07 M
|
$528.77 M
|
$494.38 M
|
$465.57 M
|
$395.31 M
|
$360.81 M
|
$320.87 M
|
Weighted Average Shares Out Diluted |
$986.70 M
|
$839.26 M
|
$682.86 M
|
$605.06 M
|
$528.82 M
|
$494.38 M
|
$465.69 M
|
$395.31 M
|
$360.80 M
|
$320.87 M
|
Link |
|
|
|
|
|
|
|
|
|
|